Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates
Not Applicable
Terminated
- Conditions
- Embryo ImplantationInfertility
- Interventions
- Other: EmbryoGlue
- Registration Number
- NCT00588250
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.
- Detailed Description
EmbryoGlue (TM) is added to embryo transfer solutions immediately prior to the transfer of frozen-thawed human embryos before placement of embryos into the patient uterus.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Frozen embryo transfer patients, men over the age of 18 and women between the ages of 18 and 42 completed years (if using their own eggs and with embryos frozen before 39 completed years) or 18 to 50 completed years if using donated eggs.
Read More
Exclusion Criteria
- Prior participation in this study, blastocyst transfers, single embryo transfer for medical reasons, prior embryo transfer with large amount of blood on the outside of the catheter, > or = 3 consecutive failed embryo transfers at Mayo Clinic (fresh or frozen-thawed cycles).
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A EmbryoGlue -
- Primary Outcome Measures
Name Time Method Pregnancy Rate one month
- Secondary Outcome Measures
Name Time Method Implantation rate two months
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States